Human papillomavirus genotypes in cervical cancer and vaccination challenges in Zimbabwe

Potential cost-effectiveness of the nonavalent human papillomavirus (HPV) vaccine

(2013) Mélanie Drolet et al.   INTERNATIONAL JOURNAL OF CANCER

The Roles of Genetic and Environmental Factors on Risk of Cervical Cancer: A Review of Classical Twin Studies

(2012) Elya E. Moore et al.   Twin Research and Human Genetics

Efficacy and Safety of Prophylactic Vaccines against Cervical HPV Infection and Diseases among Women: A Systematic Review & Meta-Analysis

(2011) Beibei Lu et al.   BMC INFECTIOUS DISEASES

Comparison of the immunogenicity and safety ofCervarix™ andGardasil®human papillomavirus (HPV) cervical cancer vaccines in healthy women aged 18–45 years

(2010) Mark H. Einstein et al.   Human vaccines & immunotherapeutics

Persistence of an Incident Human Papillomavirus Infection and Timing of Cervical Lesions in Previously Unexposed Young Women

(2009) H. Trottier et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Efficacy of HPV DNA Testing With Cytology Triage and/or Repeat HPV DNA Testing in Primary Cervical Cancer Screening

(2009) P. Naucler et al.   JNCI-Journal of the National Cancer Institute

Cervical Human Papillomavirus Incidence and Persistence in a Cohort of HIV-Negative Women in Zimbabwe

(2009) Emily Fukuchi et al.   SEXUALLY TRANSMITTED DISEASES

Epidemiology and prevention of human papillomavirus and cervical cancer in sub-Saharan Africa: a comprehensive review

(2009) Karly S. Louie et al.   TROPICAL MEDICINE & INTERNATIONAL HEALTH

A review of cross-protection against oncogenic HPV by an HPV-16/18 AS04-adjuvanted cervical cancer vaccine: Importance of virological and clinical endpoints and implications for mass vaccination in cervical cancer prevention

(2008) David Jenkins   GYNECOLOGIC ONCOLOGY

Part I: Cancer in Indigenous Africans—burden, distribution, and trends

(2008) D Max Parkin et al.   LANCET ONCOLOGY